Amanote Research
Register
Sign In
Potent Activity of a Novel Dimeric Heat Shock Protein 90 Inhibitor Against Head and Neck Squamous Cell Carcinoma in Vitro and in Vivo
Clinical Cancer Research
- United States
doi 10.1158/1078-0432.ccr-04-2272
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
May 15, 2005
Authors
X. Yin
Publisher
American Association for Cancer Research (AACR)
Related search
Preclinical Antitumor Activity of SST0116CL1: A Novel Heat Shock Protein 90 Inhibitor
International Journal of Oncology
Cancer Research
Oncology
In Vitro and in Vivo Superior Radiosensitizing Effect of Berbamine for Head and Neck Squamous Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Expression of a Novel mRNA in Human Head and Neck Squamous Cell Carcinoma Cells.
Molecular Pathology
Head and Neck: Oral Squamous Cell Carcinoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Head and Neck Squamous Cell Carcinoma in Pregnant Women
Laryngoscope
Otorhinolaryngology
Novel Microtubule Inhibitor MPT0B098 Inhibits Hypoxia-Induced Epithelial-To-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma
Journal of Biomedical Science
Cell Biology
Pharmacology
Biochemistry
Endocrinology
Clinical Biochemistry
Molecular Biology
Medicine
Metabolism
Diabetes
Antitumor Activity and Molecular Effects of the Novel Heat Shock Protein 90 Inhibitor, IPI-504, in Pancreatic Cancer
Molecular Cancer Therapeutics
Cancer Research
Oncology
An in Vivo Evaluation of Docetaxel Delivered Intratumorally in Head and Neck Squamous Cell Carcinoma
Archives of Otolaryngology–Head & Neck Surgery
In Vitro Activity of Calcineurin and Heat Shock Protein 90 Inhibitors Against Aspergillus Fumigatus Azole- And Echinocandin-Resistant Strains
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
